Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Considerations for the New Four-Month Rifapentine-Moxifloxacin Regimen for Drug-Susceptible TB in the U.S.

Webinar/Podcast
Considerations for the New Four-Month Rifapentine-Moxifloxacin Regimen for Drug-Susceptible TB in the U.S.

Presented on September 21, 2021 by the TB Centers of Excellence and the Centers for Disease Control and Prevention

Author:

Rutgers Global Tuberculosis Institute

Topic:

TB Treatment

Country of Origin:

United States

View Video

Related Materials

MMWR: Implementation of New TB Screening Requirements for U.S.-Bound Immigrants and Refugees–2007-2014

This report summarizes worldwide implementation of new TB screening requirements for foreign-born persons applying for either an immigrant visa or refugee status to enter the United States. In 2007 CDC issued Technical Instructions for Tuberculosis Screening and Treatment Using Cultures and Directly Observed Therapy (CDOT TB TI). The important changes included: sputum cultures in addition to sputum smears; tuberculin skin tests or interferon gamma release assays beginning in 2009 for certain 2-14 year-olds in countries where the World Health Organization estimates TB incidence equal to or greater than 20 per 100,000 persons; drug susceptibility testing of positive isolates; and treatment according to guidelines from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.

Report

12-dose Isoniazid/Rifapentine Regimen for Latent TB Infection Treatment

This fact sheet provides an overview of the 12-dose regimen for treating latent TB infection.

Fact Sheet

Latent TB Infection Testing and Treatment: Summary of U.S. Recommendations

This material summarizes the U.S. recommendations for latent TB infection testing and treatment. The document includes information on who should be tested for TB infection, recommended treatment regimens for latent TB infection, and more.

Fact Sheet

Global resources for the prevention,
management, and elimination of TB.